Welcome to our dedicated page for AXT SEC filings (Ticker: AXTI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AXT, Inc. filings document the regulatory disclosures of a Nasdaq-listed manufacturer of compound semiconductor substrate wafers. Recent Form 8-K reports cover results of operations and financial condition, Regulation FD information, exhibit filings for earnings releases, and capital-structure disclosures involving its common stock.
The filing record also includes material definitive agreement disclosure for an underwriting agreement, exchange-registration information for AXTI common stock, and definitive proxy materials addressing shareholder voting matters, board and committee governance, director independence, and executive compensation.
AXT Inc. CEO Morris S. Young reported two bona fide gift transfers of AXT common stock on March 2, 2026. The Form 4 shows indirect dispositions of 17,200 shares and 10,000 shares at a stated price of $0.00 per share, held through the Young Family Trust DTD. Following these gifts, indirect ownership reported for this security was 2,641,574 shares.
AXT Inc Chief Financial Officer Gary L. Fischer sold 405,233 shares of common stock in an open-market transaction on March 2, 2026. The weighted average sale price was $41.455 per share, with individual trades ranging from $40.00 to $45.82. After these sales, Fischer directly owns 280,310 shares of AXT common stock.
Charles Schwab Corp. submitted a Form 144 notice describing proposed sales of specified restricted stock grants and disclosing recent affiliate sales. The filing lists restricted grants dated 07/01/2015 (10,787 shares), 06/03/2016 (8,223), 05/03/2017 (13,761), 06/09/2017 (24,831), and 06/06/2018 (12,807).
The filing also reports securities sold during the past three months by David C. Chang: 25,000 shares on 12/09/2025 for $371,012 and 25,000 shares on 12/02/2025 for $308,361. The notice records Nasdaq listing and an aggregate figure line showing 60,000 and 2,779,200.00 in the header data.
AXT Inc CFO Gary L. Fischer reported a series of stock option exercises and related share acquisitions in AXT Inc common stock. On February 26, 2026, he exercised multiple fully vested stock options that were originally granted between 2016 and 2019 and had become exercisable between 2017 and 2020, converting them into common shares at preset exercise prices. Following these transactions, Fischer directly owned 685,543 shares of AXT Inc common stock.
AXT Inc. filed a Form 144 disclosing proposed sales of multiple common shares linked to performance stock awards, including 27,949, 5,501, 98,137, and 27,949 shares with award dates in 10/28/2025, 10/29/2025, 11/10/2025, and 11/11/2025
The filing also reports insider sales by Morris S. Young of 35,000 shares on 12/04/2025 for $421,652.00 and 37,160 shares on 12/08/2025 for $462,909.55.
AXT, Inc. submitted notices under Section 144 reporting proposed sales of common stock tied to prior stock option exercises and restricted stock awards. The filing lists multiple planned dispositions with individual lots and dates, including examples such as 62,560 shares (11/06/2019) and 42,300 shares (10/28/2016).
YOUNG MORRIS S reported acquisition or exercise transactions in this Form 4 filing.
AXT Inc. reported that CEO and director Morris S. Young received an award of 218,170 shares of common stock as at-risk performance share awards (PSAs) under the company’s 2015 Equity Incentive Plan. These PSAs were approved on February 18, 2025 and are eligible to vest based on achieving certain financial metrics for fiscal year 2025. The grant represents 97.6% of the maximum PSAs issuable to him for exceeding those FY2025 targets. Following this award, Young directly holds 2,668,774 shares of AXT common stock.
AXT Inc. reported that its CFO, Gary L. Fischer, acquired 75,718 shares of common stock on February 18, 2026 through a grant with no cash price per share. This award consists of at-risk performance share awards under the company’s 2015 Equity Incentive Plan.
The performance shares are eligible to vest only if certain target financial metrics for fiscal year 2025 are achieved. The filing states that the 75,718 performance shares represent 97.6% of the maximum number of performance shares that could be issued to the CFO for exceeding those FY2025 targets. After this grant, Fischer held 437,715 shares of AXT common stock directly.
AXT, Inc. reported weaker fourth quarter and full-year 2025 results, with ongoing investment in AI-related growth. Q4 2025 revenue was $23.0M versus $25.1M a year earlier, while full-year revenue declined to $88.3M from $99.4M. Net loss attributable to AXT widened to $3.5M in Q4 and $21.3M for 2025, compared with losses of $5.1M and $11.6M in 2024. On a non-GAAP basis, 2025 net loss was $18.0M. Despite losses, cash and cash equivalents rose sharply to $120.3M at December 31, 2025, supporting plans to double indium phosphide manufacturing capacity in 2026. Management expects sequential revenue growth in Q1 2026, driven mainly by indium phosphide demand for AI infrastructure, and continues to pursue a potential STAR Market IPO of its Tongmei subsidiary, which remains subject to regulatory review in China.